Home – Cell Symposia: Stem cells in modeling and treating disease …

VIEW PROGRAM HERE

Keynote Speakers

George Q. Daley, Boston Children's Hospital, Harvard Medical School, USA Sally Temple, Neural Stem Cell Institute, Rensselaer, USA

Confirmed Speakers

Juan Carlos Izpisua Belmonte, Salk Institute, USA / CMRB, Spain Chad Cowan, Harvard University, USA Kevin Eggan, Harvard University, USA Fred H. Gage, Salk Institute, USA Steven A. Goldman, University of Rochester Medical Center, USA Eduardo Marbn, Cedars-Sinai, USA Daniel R. Marshak, PerkinElmer Christine Mummery, Leiden University Medical Centre, The Netherlands Janet Rossant, Hospital for Sick Children, Toronto, Canada Peter G. Schultz, Scripps Research Institute, USA Deepak Srivastava, Gladstone Institute, USA Lorenz Studer, Memorial Sloan-Kettering Cancer Center, USA Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute, USA Alan Trounson, CIRM, USA Nobuko Uchida, StemCells Inc., USA Amy J. Wagers, Harvard University, Joslin Diabetes Center, USA Leonard I. Zon, Boston Children's Hospital, Harvard Medical School, USA

Organizing Committee

Gabriel Hayes, Scientific Editor, Cell Christina Lilliehook, Senior Scientific Editor, Cell Stem Cell Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute, USA

The Nobel Prize in Physiology and Medicine 2012 was awarded to Shinya Yamanaka and John Gurdon for their discovery that mature cells can be reprogrammed to become pluripotent. Their work has now galvanized the stem cell field into generating patient-derived induced pluripotent stem cells (iPSCs) and using these to model and treat human disease. While these efforts are still in their infancy, other types of stem cells are closer to the clinic, and some of them are moving through clinical trials. The overall goal of the symposium is to bring these two areas of stem cell research together to accelerate progress in the field.

The rest is here:
Home - Cell Symposia: Stem cells in modeling and treating disease ...

Related Post